NovaBridge Biosciences (NBP) Current Assets (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Current Assets data on file, last reported at $217.5 million in Q4 2025.

• Quarterly Current Assets rose 23.11% year-over-year to $217.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $217.5 million (up 23.11% YoY) and the FY2025 annual result came in at $217.5 million, up 23.11% from the prior year.
• Current Assets eased to $217.5 million in Q4 2025 per NBP's latest filing, from $232.8 million in the prior quarter.
• Across five years, Current Assets topped out at $747.9 billion in Q4 2021 and bottomed at $167.6 million in Q2 2025.
• The 5-year median for Current Assets is $232.8 million (2025), against an average of $57.8 billion.
• The widest annual swing landed in 2021, when Current Assets soared 92655.2%; it then tumbled 99.93% in 2022.
• Tracing NBP's Current Assets over 5 years: stood at $747.9 billion in 2021, then plunged by 99.93% to $509.9 million in 2022, then plunged by 36.35% to $324.5 million in 2023, then slumped by 45.55% to $176.7 million in 2024, then increased by 23.11% to $217.5 million in 2025.
• Per Business Quant, the three latest NBP Current Assets figures stand at $217.5 million (Q4 2025), $232.8 million (Q3 2025), and $167.6 million (Q2 2025).

Peer Comparison